Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients

Silent diabetic nephropathy

(2016) Samar M. Said et al.   KIDNEY INTERNATIONAL

Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy

(2015) Jingping Liu et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Metabolomics and Diabetes: Analytical and Computational Approaches

(2015) Kelli M. Sas et al.   DIABETES

Mitochondrial Hormesis and Diabetic Complications: Figure 1

(2015) Kumar Sharma   DIABETES

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

(2015) B. Schievink et al.   DIABETES OBESITY & METABOLISM

Mitochondria: a new therapeutic target in chronic kidney disease

(2015) Simona Granata et al.   Nutrition & Metabolism

Association of 1,5-Anhydroglucitol with Diabetes and Microvascular Conditions

(2014) E. Selvin et al.   CLINICAL CHEMISTRY

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

(2014) M. J. Pena et al.   DIABETIC MEDICINE

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development

(2014) Hyun Mi Kang et al.   NATURE MEDICINE

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies

(2014) Ling Li et al.   BMC Nephrology

Glycine metabolism in animals and humans: implications for nutrition and health

(2013) Weiwei Wang et al.   AMINO ACIDS

Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

(2013) G C Higgins et al.   BRITISH JOURNAL OF PHARMACOLOGY

Urinary liver type fatty acid binding protein in diabetic nephropathy

(2013) Atsuko Kamijo-Ikemori et al.   CLINICA CHIMICA ACTA

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

(2013) Laura L. Dugan et al.   JOURNAL OF CLINICAL INVESTIGATION

Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy

(2013) Michal Herman-Edelstein et al.   JOURNAL OF LIPID RESEARCH

Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease

(2013) K. Sharma et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy

(2013) Jingping Liu et al.   Molecular BioSystems

The effect of RAAS blockade on the progression of diabetic nephropathy

(2013) Sara S. Roscioni et al.   Nature Reviews Nephrology

Uric Acid as a Target of Therapy in CKD

(2012) Diana I. Jalal et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy

(2012) Akiyoshi Hirayama et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Metabolomics: the apogee of the omics trilogy

(2012) Gary J. Patti et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

PPARs: Fatty acid sensors controlling metabolism

(2012) Lars la Cour Poulsen et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction

(2011) W. J. Kim et al.   DIABETES CARE

The role of mitochondria in insulin resistance and type 2 diabetes mellitus

(2011) Julia Szendroedi et al.   Nature Reviews Endocrinology

Renal lipid metabolism and lipotoxicity

(2010) Ion Alexandru Bobulescu   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Albumin as Fatty Acid Transporter

(2009) Ger J. van der Vusse   Drug Metabolism and Pharmacokinetics

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1 

(2008) R. Ventura-Clapier et al.   CARDIOVASCULAR RESEARCH